Registry following people treated with neurovascular devices for brain conditions
Follows adults treated with devices for brain aneurysms or ischemic stroke.
Plain-language title generated from the registry record
Registry title: Neurovascular Product Surveillance Registry
Key facts
- Where
- Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Dijon, Le Kremlin-Bicêtre, Limoges, Marseille, Montpellier, Nancy, Nantes, Paris, Reims, Rouen, Toulouse, Tours, and Vannes, FranceSee the 21 sites
Where in France
- CHU Besancon - Hopital Jean MinjozBesançon, FranceTaking people
- CHU de Bordeaux - Centre Universitaire PellegrinBordeaux, FranceNo longer taking part
- CHU Brest Hôpital de la Cavale BlancheBrest, FranceTaking people
- Hôpital Pierre WertheimerBron, FranceTaking people
- CHU de CAENCaen, FranceNo longer taking part
- Centre Hospitalier Universitaire de Clermont Ferrand - Gabriel MontpiedClermont-Ferrand, FranceNo longer taking part
- Chu Dijon BourgogneDijon, FranceNo longer taking part
- AP-HP Hopital BicetreLe Kremlin-Bicêtre, FranceTaking people
- CHU Limoges - Hôpital DupuytrenLimoges, FranceTaking people
- Hôpital de la Timone-CHU de MarseilleMarseille, FranceTaking people
- CHU de Montpellier - Hôpital Gui de ChauliacMontpellier, FranceTaking people
- CHU de Nancy -Hôpital CentralNancy, FranceNo longer taking part
- CHU de Nantes - Hôpital LaennecNantes, FranceNo longer taking part
- Fondation Ophtalmologique Adolphe de RothschildParis, FranceTaking people
- Hôpital de la Pitié-SalpêtrièreParis, FranceTaking people
- GHU Paris Psychiatrie & NeurosciencesParis, FranceNo longer taking part
- CHU Reims Hôpital Maison BlancheReims, FranceNo longer taking part
- CHU Hôpitaux de Rouen - Hôpital Charles NicolleRouen, FranceTaking people
- CHU Toulouse - Hôpital Pierre-Paul RiquetToulouse, FranceTaking people
- CHRU de Tours - Hôpital BrettoneauTours, FranceTaking people
- Centre Hospitalier Bretagne Atlantique Vannes - AurayVannes, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medtronic Neurovascular Clinical Affairs
- Trial code
- NCT02988128
- Record updated
- 15 September 2026
- Original description
Post market surveillance registryRead full original descriptionShow less
NeuroVascular Product Surveillance Registry (PSR) Platform
Post market surveillance registry
Inclusion: Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient has, or is intended to receive or be treated with, an eligible Medtronic product; Patient is consented within the enrollment window of the therapy received, as applicable; Patient is at least 18 years of age at time of enrollment.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient is treated or intended to be treated with an eligible Medtronic Neurovascular product; Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results; Additional criteria may be required, refer to cohort-specific Addendum, as applicable, for further guidance; Patient who is, or is expected to be inaccessible for follow-up; Patient with exclusion criteria required by local law; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study; For MDT24028 and MDT22032:; General Inclusion Criteria:; Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient is an adult per local law at time of consent. Medtronic Business Restricted This document is electronically controlled CONFIDENTIAL 056-F275 Rev F Clinical Investigation Plan Template; General Exclusion Criteria:; Patient who may be unable to complete the study follow-up; Patient with any contraindications per the applicable Instructions for Use document; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
For MDT16056 and MDT17077.